About
to enjoy learning and progressing in cardiometabolic practice
Daily cardiology
English, Health / Medicine, 1 season, 524 episodes, 3 days, 30 minutes
Daily cardiology
English, Health / Medicine, 1 season, 524 episodes, 3 days, 30 minutes
Impact: Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention
Impact: SAPT 1 year after PCI
1/30/2024 • 6 minutes, 7 seconds
Impact: Validity of a speech analysis app for the prediction of HF worseningImpact: Speech analysis
Impact: Speech analysis to predict HF events, Cordio HearO
1/30/2024 • 3 minutes, 14 seconds
Case Discussion 109 Answer: GI protection in patients on single antiplatelet therapy
Case Discussion 109 Answer: GI protection in SAPT
1/30/2024 • 6 minutes, 56 seconds
Case Discussion 110 Answer: Tapering off medical therapy in acute idiopathic pericarditis
Case Discussion 110 Answer: Medical therapy in acute pericarditis
1/30/2024 • 4 minutes, 26 seconds
Hypertension and Hyperlipidemia Academy, No. 15 - Part 2
15th H&H Academy
1/19/2024 • 1 hour, 12 minutes, 1 second
Hypertension and Hyperlipidemia Academy, No. 15 - Part 1
15th H&H Academy
1/18/2024 • 1 hour, 14 minutes, 54 seconds
Diabeat, 9th session: is Metformin still the champion for T2D and heart disease? a debate: Pros
Diabeat 9th session, case based discussion
1/10/2024 • 33 minutes, 48 seconds
Diabeat, 9th session: is Metformin still the champion for T2D and heart disease? a debate: Cons
Diabeat 9th session, case based discussion
1/10/2024 • 20 minutes, 28 seconds
Diabeat: the 9th diabetes masterclass for cardiologists, case-based discussion
Diabeat 9th session, case based discussion
1/2/2024 • 1 hour, 43 minutes, 27 seconds
Hypertension and Hyperlipidemia Academy, No. 14 - Part 2
14th H&H Academy
1/1/2024 • 58 minutes, 1 second
Hypertension and Hyperlipidemia Academy, No. 14 - Part 1
14th H&H Academy
1/1/2024 • 1 hour, 31 minutes, 47 seconds
Case Discussion 98 Answer: Long term anticoagulation after cerebral venous sinus thrombosis
Case Discussion 98 Answer: Anticoagulation after cerebral venous sinus thrombosis
12/11/2023 • 9 minutes, 19 seconds
H&H Academy in 7-minutes, Episode 1
H&H in 7 minutes, 1
12/11/2023 • 7 minutes, 18 seconds
Case Discussion 103 Answer: Approach to the management of Ascending Aorta Dilation
Case Discussion 103 Answer: Ascending Aorta Dilation
12/4/2023 • 12 minutes, 43 seconds
AHA23 Congress Coverage: A Placebo-Controlled Trial of PCI for Stable Angina: The ORBITA-2 trial
AHA23 Congress Coverage: PCI for Stable Angina (ORBITA-2 Trial)
12/4/2023 • 9 minutes, 8 seconds
AHA23 Congress Coverage: Impact of Female Sex on Cardiogenic Shock Outcomes
AHA23 Congress Coverage: Cardiogenic Shock in Women
12/4/2023 • 2 minutes, 20 seconds
AHA23 Congress Coverage: Lepodisiran Dose-Ascending Trial
AHA23 Congress Coverage: Lepodisiran Dose-Ascending Trial
12/4/2023 • 5 minutes, 5 seconds
AHA23 Congress Coverage: Daily Marijuana Use is Associated With HF: “All of Us” Research Program
AHA23 Congress Coverage: Daily Marijuana and HF ("All of Us Research Program")
12/3/2023 • 3 minutes, 1 second
AHA23 Congress Coverage: Long-Term BP Control After Hypertensive Pregnancy: The POP-HT trial
AHA23 Congress Coverage: BP control after hypertensive pregnancy (POP-HT)
12/3/2023 • 5 minutes
AHA23 Congress Coverage: Hypertension Treatment and Risk of Dementia
AHA23 Congress Coverage: HTN and Dementia
11/20/2023 • 3 minutes, 13 seconds
AHA23 Congress Coverage: Apixaban for Stroke Prevention in Subclinical AF: ARTESIA trial
AHA23 Congress Coverage: Apixaban in subclinical AF (ARTESIA)
11/20/2023 • 7 minutes, 21 seconds
AHA23 Congress Coverage: Semaglutide and Cardiovascular Outcomes in Obesity without DM: SELECT trial
AHA23 Congress Coverage: Semaglutide in obesity and no DM (SELECT trial)
11/20/2023 • 5 minutes, 9 seconds
AHA23 Congress Coverage: Dapagliflozin in Myocardial Infarction without DM or HF: DAPA-MI trial
AHA23 Congress Coverage: Dapagliflozin in MI without DM or HF (DAPA MI)
11/20/2023 • 3 minutes, 54 seconds
AHA23 Congress Coverage: Dapagliflozin in Myocardial Infarction without DM or HF: DAPA-MI trial
AHA23 Congress Coverage: Dapagliflozin in MI without DM or HF (DAPA MI)
11/20/2023 • 3 minutes, 54 seconds
AHA23 Congress Coverage: Restrictive or Liberal Transfusion Strategy in MI and Anemia: MINT trial
AHA23 Congress Coverage: Blood Transfusion in MI and Anemia (MINT trial)
11/20/2023 • 4 minutes, 51 seconds
Case Discussion 102: Diagnosis and management of Retroaortic Anomalous Coronary Artery
Case Discussion 102: Retroaortic Anomalous Coronary Artery
11/20/2023 • 6 minutes, 56 seconds
Case Discussion 102: Approach to the diagnosis & management of Retroaortic Anomalous Coronary Artery
Case Discussion 102: Retroaortic Anomalous Coronary Artery
11/14/2023 • 6 minutes, 56 seconds
Case Discussion 101: ICD implantation in patients with non-ischemic dilated cardiomyopathy
Case Discussion 100: ICD in non-ischemic dilated CMP
11/4/2023 • 12 minutes, 36 seconds
Case Discussion 100: Management of asymptomatic congenital anomaly of the right coronary artery
Case Discussion 100: Congenital right coronary anomaly
10/31/2023 • 5 minutes, 1 second
Stage 1 hypertension: treat or not?
Stage 1 HTN treatment
10/30/2023 • 23 minutes
Light Rounds Volume 6: Elderly gentleman with T2D, CAD and foot ulcer
Light Round Volume 6: Approach to a patient with an ischemic foot ulcer
10/22/2023 • 38 minutes, 34 seconds
Light Rounds Volume 5: 22 Y/O lady with frequent PVCs
Light Round Volume 5: Approach to a patient with frequent PVCs
10/16/2023 • 37 minutes, 13 seconds
Impact: When Does a Calcium Score Equate to Secondary Prevention?
Impact: New Evidence for Interpreting Calcium Score
10/10/2023 • 5 minutes, 42 seconds
Case Discussion 99: P2Y12 inhibitors in STEMI patients treated with Fibrinolytics and undergoing PCI
Case Discussion 99: P2Y12 choice for PCI after fibrinolytic Tx
10/10/2023 • 7 minutes, 12 seconds
AI and Medicine, a chat with the creator of DocSplain
DocSplain Interview
9/24/2023 • 28 minutes, 59 seconds
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of CVD in patients with diabetes
ESC 2023: New DM and CVD Guideline
9/18/2023 • 33 minutes, 30 seconds
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of endocarditis
ESC 2023: New Endocarditis Guideline
9/18/2023 • 24 minutes, 46 seconds
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of cardiomyopathies
ESC 2023: New Cardiomyopathies Guideline
9/18/2023 • 23 minutes, 44 seconds
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of acute coronary syndromes
ESC 2023: ACS Guidelines
9/10/2023 • 24 minutes, 38 seconds
ESC 2023 Congress Coverage: 2023 Focused Update of the 2021 HF Guideline
ESC 2023: HF Guideline Update
9/10/2023 • 6 minutes, 41 seconds
ESC 2023 Congress Coverage: OPT-BIRISK
ESC 2023: OPT-BIRISK
9/2/2023 • 4 minutes, 35 seconds
Stage 1 hypertension at a glance
Stage 1 HTN
9/2/2023 • 26 minutes, 19 seconds
ESC 2023 Congress Coverage: HEART-FID
ESC 2023: HEART-FID
9/2/2023 • 4 minutes, 8 seconds
ESC 2023 Congress Coverage: BUDAPEST-CRT Upgrade
ESC 2023: BUDAPEST-CRT Upgrade
9/2/2023 • 2 minutes, 59 seconds
ESC 2023 Congress Coverage: STOP-DAPT 3
ESC 2023: STOP-DAPT 3
9/2/2023 • 2 minutes, 47 seconds
ESC 2023 Congress Coverage: RED-CVD
ESC 2023: RED-CVD
9/2/2023 • 2 minutes, 52 seconds
ESC 2023 Congress Coverage: ARAMIS
ESC 2023: ARAMIS
9/2/2023 • 3 minutes, 31 seconds
ESC 2023 Congress Coverage: ATTRibute CM
ESC 2023: ATTRibute
9/2/2023 • 5 minutes, 41 seconds
Overview of ESC 2023 Congress
What to expect from ESC 2023
9/2/2023 • 11 minutes, 51 seconds
ESC 2023 Congress Coverage: ONCO-DVT
ESC 2023: ONCO-DVT
9/2/2023 • 1 minute, 43 seconds
ESC 2023 Congress Coverage: FIRE
ESC 2023: FIRE
9/2/2023 • 4 minutes, 52 seconds
ESC 2023 Congress Coverage: ADVENT
ESC 2023: ADVENT
9/2/2023 • 4 minutes, 35 seconds
ESC 2023 Congress Coverage: RIGHT
ESC 2023: RIGHT
9/2/2023 • 3 minutes, 38 seconds
ESC 2023 Congress Coverage: ARREST
ESC 2023: ARREST
9/2/2023 • 2 minutes, 48 seconds
ESC 2023 Congress Coverage: NOAH-AFNET 6
ESC 2023: NOAH-AFNET 6
9/2/2023 • 3 minutes, 43 seconds
ESC 2023 Congress Coverage: MULTISTARS AMI
ESC 2023: MULTISTARS AMI
9/2/2023 • 3 minutes, 19 seconds
ESC 2023 Congress Coverage: CASTLE-HTx
ESC 2023: CASTLE-HTx
9/2/2023 • 2 minutes, 21 seconds
ESC 2023 Congress Coverage: COP-AF
ESC 2023: COP-AF
9/2/2023 • 5 minutes, 41 seconds
ESC 2023 Congress Coverage: DICTATE-AHF
ESC 2023: DICTATE-AHF
9/2/2023 • 5 minutes, 6 seconds
ESC 2023 Congress Coverage: STEP-HFpEF
ESC 2023: STEP-HFpEF
9/2/2023 • 4 minutes, 40 seconds
ESC 2023 Congress Coverage: QUEST
ESC 2023: QUEST
9/2/2023 • 4 minutes, 14 seconds
ESC 2023 Congress Coverage: NITRATE-CIN
ESC 2023: NITRATE-CIN
9/2/2023 • 5 minutes, 20 seconds
ESC 2023 Congress Coverage: PUSH-AHF
ESC 2023: PUSH-AHF
9/2/2023 • 2 minutes, 12 seconds
Impact: Clinical Outcomes of Calcium Channel Blockers versus Beta Blockers after Acute MI
Impact: CCBs VS BBs post AMI
8/24/2023 • 5 minutes, 10 seconds
Case Discussion 76 Answer
Case Discussion 76 Answer
8/24/2023 • 4 minutes, 33 seconds
Apical Hypertrophic Cardiomyopathy, a narrative review
Apical HCM
8/24/2023 • 15 minutes, 29 seconds
Case Discussion 97 Answer
Case Discussion 97 Answer
8/24/2023 • 6 minutes, 31 seconds
Impact: Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
Impact: Zilebesiran
8/17/2023 • 6 minutes, 3 seconds
Impact: Combination lipid-lowering therapy after PCI
Impact: Dyslipidemia treatment after PCI
8/12/2023 • 4 minutes, 24 seconds
Hypertension and Hyperlipidemia Academy Session - Part 1
H&H Academy session
8/12/2023 • 1 hour, 53 minutes, 51 seconds
Case Discussion 95 Answer
Case Discussion 95 Answer
8/12/2023 • 10 minutes, 6 seconds
Impact: Early versus Later Anticoagulation for Stroke with Atrial Fibrillation
Impact: Anticoagulation in AF and stroke
8/12/2023 • 7 minutes, 19 seconds
Hypertension and Hyperlipidemia Academy Session - Part 2
H&H Academy session
8/12/2023 • 56 minutes, 14 seconds
NEJM Knowledge plus Case Discussion
a Case Discussion from NEJM Knowledge plus service
7/31/2023 • 6 minutes, 51 seconds
Daily Cardiology Symposium 1402 Day 2 Panel 1
Acute Pericarditis and Cardiac Tamponade
7/31/2023 • 1 hour, 47 minutes, 48 seconds
Daily Cardiology’s Young Cardiologist Award 1402 Final
YCA 1402 final
7/31/2023 • 2 hours, 2 minutes, 12 seconds
Daily Cardiology Symposium 1402 Day 2 Panel 4
Infective Endocarditis and Prosthetic Valve Malfunction
7/31/2023 • 1 hour, 36 minutes, 45 seconds
Daily Cardiology Symposium 1402 Day 2 Panel 3
Chronic Limb-Threatening Ischemia and Acute Aortic Syndromes
7/31/2023 • 1 hour, 48 minutes, 17 seconds
Daily Cardiology Symposium 1402 Day 2 Panel 2
Acute DVT and Acute PE
7/31/2023 • 1 hour, 41 minutes, 2 seconds
Daily Cardiology Symposium 1402 Day 1 Panel 2
Acute De Novo Heart Failure and Cardiogenic Shock
7/31/2023 • 1 hour, 30 minutes, 54 seconds
Daily Cardiology Symposium 1402 Day 1 Panel 4
Hypertension Crisis and Acute Hypertension in Pregnancy
7/31/2023 • 1 hour, 41 minutes, 50 seconds
Daily Cardiology Symposium 1402 Day 1 Panel 3
Acute Coronary Syndrome and Acute Chest Pain
7/31/2023 • 1 hour, 31 minutes, 4 seconds
Daily Cardiology Symposium 1402 Day 1 Panel 1
Cardiopulmonary resuscitation and Narrow-complex Tachyarrhythmia
7/31/2023 • 1 hour, 44 minutes, 1 second
Daily Cardiology Symposium 1402 Welcome Remarks
DCS 1402 Welcome Remarks
7/31/2023 • 12 minutes, 51 seconds
Case Discussion 78 Answer
Case Discussion 78 Answer
7/24/2023 • 11 minutes, 8 seconds
Case Discussion 93 Answer
Case Discussion 93 Answer
7/24/2023 • 6 minutes, 2 seconds
Light Rounds Volume 4: middle-aged gentleman with HTN, T2D and erythrocytosis
Light Rounds Volume 4: middle-aged gentleman with HTN, T2D and erythrocytosis
7/16/2023 • 20 minutes, 40 seconds
Case Discussion 84 Answer
Case Discussion 84 Answer
7/16/2023 • 7 minutes, 24 seconds
Case Discussion 88 Answer
Case Discussion 88 Answer
7/16/2023 • 9 minutes, 12 seconds
Vision: Adults with fasting TG=150-500mg with ACVD or DM
Vision: Mild hypertriglyceridemia in moderate to high risk patients
7/16/2023 • 9 minutes, 26 seconds
Case Discussion 85 Answer
Case Discussion 85 Answer
7/16/2023 • 9 minutes, 1 second
Case Discussion 79 Answer
Case Discussion 79 Answer
7/1/2023 • 6 minutes, 9 seconds
Case Discussion 91 Answer
Case Discussion 91 Answer
7/1/2023 • 10 minutes, 27 seconds
Case Discussion 87 Answer
Case Discussion 87 Answer
6/25/2023 • 5 minutes, 30 seconds
Cardiac considerations and monitoring in patients receiving Acetylcholinesterase inhibitors
Acetylcholinesterase inhibitors' cardiac considerations
6/17/2023 • 11 minutes, 41 seconds
Case Discussion 75 Answer
Case Discussion 75 Answer
6/17/2023 • 3 minutes, 46 seconds
PROMIS-II trial explained
Arterialization of deep veins in CLTI
6/17/2023 • 10 minutes, 37 seconds
Case Discussion 72 Answer
Case Discussion 72 Answer
6/17/2023 • 7 minutes, 34 seconds
Case Discussion 82 Answer
Case Discussion 82 Answer
6/10/2023 • 17 minutes, 7 seconds
Light Rounds Volume 3: elderly gentleman with ICMP and LV thrombus
Light Rounds 3: LV thrombus
6/10/2023 • 29 minutes, 5 seconds
InstaCath Conference 20 Answer
InstaCath Conference 20 Answer
6/2/2023 • 11 minutes, 15 seconds
Case Discussion 77 Answer
Case Discussion 77 Answer
6/2/2023 • 9 minutes, 17 seconds
Hypertension and Hyperlipidemia Academy: clinical tips for nurses and non-physicians - Part 2
H&H Academy: clinical tips for non-physicians
6/2/2023 • 1 hour, 3 minutes, 52 seconds
Case Discussion 80 Answer
Case Discussion 80 Answer
6/2/2023 • 8 minutes, 16 seconds
Hypertension and Hyperlipidemia Academy: clinical tips for nurses and non-physicians - Part 1
H&H Academy: clinical tips for non-physicians
6/2/2023 • 1 hour, 19 seconds
InstaCath Conference 21 Answer
InstaCath Conference 21 Answer
5/26/2023 • 6 minutes, 18 seconds
Case Discussion 81 Answer
Case Discussion 81 Answer
5/26/2023 • 13 minutes
American College of Cardiology (ACC) 2023 Congress Coverage - Part 2
ACC.23 Congress Coverage
5/26/2023 • 46 minutes, 2 seconds
American College of Cardiology (ACC) 2023 Congress Coverage - Part 1
ACC.23 Congress Coverage
5/26/2023 • 1 hour, 12 minutes, 25 seconds
Case Discussion 73 Answer
Case Discussion 73 Answer
5/26/2023 • 11 minutes, 1 second
Hypertension and Hyperlipidemia Academy 12th session - Part2
H&H Academy 12
5/26/2023 • 1 hour, 8 minutes, 30 seconds
Case Discussion 74 Answer
Case Discussion 74 Answer
5/26/2023 • 4 minutes, 33 seconds
Hypertension and Hyperlipidemia Academy 12th session - Part 1
H&H Academy 12
5/26/2023 • 1 hour, 8 minutes, 55 seconds
Light Rounds Volume 2: young gentleman with recurrent syncope
Light Rounds 2: Syncope
5/12/2023 • 26 minutes, 7 seconds
Should ACS patients start a PCSK9i in the hospital?
PCSK9i in the ACS setting
5/12/2023 • 27 minutes, 29 seconds
Impact: Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients With HF
Impact: Sacubitril/Valsartan and renal function in HF
5/12/2023 • 4 minutes, 39 seconds
InstaCath Conference Number 22 Answer
InstaCath Conference 22
5/12/2023 • 5 minutes, 40 seconds
Vision: Adults with fasting TG=150-500mg without ACVD or DM
Vision: Mild hypertriglyceridemia in low-risk patients
4/15/2023 • 7 minutes, 20 seconds
Dyslipidemia management in patients with diabetes
Management of DLP in TD2
4/8/2023 • 22 minutes, 56 seconds
Case Discussion 71 Answer
Case Discussion 71 Answer
3/14/2023 • 16 minutes, 19 seconds
Hypertension and Hyperlipidemia Academy: Smoothing the path to CVD risk reduction - Part 2
H&H Academy: CVD risk reduction
3/14/2023 • 1 hour, 20 minutes, 37 seconds
Light Rounds Volume 1: a middle-aged lady with WPW in ECG
Light Rounds 1: WPW
3/14/2023 • 25 minutes, 6 seconds
Hypertension and Hyperlipidemia Academy: Smoothing the path to CVD risk reduction - Part 1
H&H Academy: CVD risk reduction
3/14/2023 • 1 hour, 3 minutes, 18 seconds
Impact: Healthy Eating Patterns and Risk of Total and Cause-Specific Mortality
Impact: Healthy Eating and mortality risk
2/22/2023 • 3 minutes, 39 seconds
CardioWatch, Season 2 Episode 6
CardioWatch S02E06
2/22/2023 • 10 minutes, 15 seconds
Impact: Survival difference in dyspnea and chest pain as an initial symptom of NSTEMI
Impact: Dyspnea vs. Chest Pain in the survival of NSTEMI patients
2/9/2023 • 3 minutes, 34 seconds
Case Discussion 70: Potassium supplementation in mild to moderate Hypokalemia
Case Discussion 70: Management of mild to moderate Hypokalemia
1/23/2023 • 6 minutes, 44 seconds
Impact: Management of ACS in older adults, an AHA statement
Impact: ACS in the elderly
12/26/2022 • 6 minutes, 45 seconds
Impact: single chest x-ray could predict 10-year CVD risk
Impact: one CXR to determine 10-yr CVD risk
12/26/2022 • 4 minutes, 5 seconds
Case Discussion No. 68 Answer: anticoagulation in pregnancy
Case Discussion No. 68 Answer
12/26/2022 • 7 minutes, 37 seconds
PANTHER: Clopidogrel overcoming the old rival
A quick review on PANTHER study
12/11/2022 • 13 minutes, 31 seconds
CardioWatch, Season 2 Episode 5
CardioWatch S02E05
12/11/2022 • 12 minutes, 48 seconds
Impact: The association between dairy intake and risk of CVD in patients with stable angina pectoris
Impact: Dairy consumption and cardiovascular risk
11/23/2022 • 4 minutes, 10 seconds
Impact: The impact of coffee subtypes on incident CVD, arrhythmias, and mortality
Impact: Coffee consumption and CV risk
11/17/2022 • 3 minutes, 53 seconds
Impact: Experts Express Caution Over Type 2 Diabetes-Tea Drinking Claim
Impact: Tea consumption and DM risk
11/17/2022 • 5 minutes, 33 seconds
Impact: Dual antiplatelet therapy with Ticagrelor and graft failure after CABG
Dual antiplatelet Tx. with Ticagrelor and graft failure after CABG
11/10/2022 • 8 minutes
Impact: Improved Likelihood of Survival With the Use of the Head-Up CPR Bundle for Non-Shockable Car
Impact: Improved Survival With the Head-Up CPR Bundle for Non-Shockable Cardiac Arrest
11/3/2022 • 5 minutes, 15 seconds
Impact: Acetaminophen in comparison to NSAIDs in cardiovascular diseases
Impact: Acetaminophen vs. NSAIDs in CVD
11/3/2022 • 3 minutes, 12 seconds
Impact: RADIANCE II: Pivotal study, renal denervation for stage II Hypertension
Impact: RADIANCE II, pivotal study
11/3/2022 • 6 minutes, 20 seconds
Impact: Pulmonary Artery Denervation for Pulmonary Arterial Hypertension
Impact: Pulmonary Artery Denervation for PAH
10/23/2022 • 4 minutes, 27 seconds
Impact: Association of Sacubitril/Valsartan administration and the severity of functional MR in HFrE
Impact: Sacubitril/Valsartan and MR severity in HFrEF
10/23/2022 • 5 minutes, 22 seconds
Impact: Effect of statin therapy on muscle symptoms
Impact: Effect of statin therapy on muscle symptoms
10/10/2022 • 4 minutes, 27 seconds
Case Discussion 59 Answer
Case Discussion 59 Answer
9/26/2022 • 6 minutes, 49 seconds
Vision: Vol. 3, Antithrombotic therapy for surgical bioprosthetic valves and valve repair
Vision, 3rd episode: antithrombotic Tx. in bioprosthetic valves and valve repair
9/26/2022 • 5 minutes, 27 seconds
Case Discussion 52 Answer
Case Discussion 52 Answer
9/26/2022 • 7 minutes, 22 seconds
Case Discussion 60 Answer
Case Discussion 60 Answer
9/26/2022 • 9 minutes, 48 seconds
Case Discussion 57 Answer
Case Discussion 57 Answer
9/26/2022 • 5 minutes, 14 seconds
Care Gaps in Adherence to Heart Failure Guidelines
Care Gaps in Adherence to Heart Failure Guidelines
9/17/2022 • 39 minutes, 1 second
Instacath Conference 18
Instacath Conference 18
9/17/2022 • 4 minutes, 51 seconds
Umbrella: Heart Failure, Panel 1, Pharmacotherapy in HFrEF
Umbrella: HF, Pharmacotherapy in HFrEF
9/16/2022 • 1 hour, 35 minutes, 11 seconds
Umbrella: Heart Failure, Panel 2, Non-pharmacologic Approach to HF Management
Umbrella: HF, Non-pharmacologic Approach to HF
9/16/2022 • 1 hour, 39 minutes, 23 seconds
Umbrella: Heart Failure, Panel 4, Heart Failure with EF more than 40%
Umbrella: HF, Heart Failure with EF>40%
9/16/2022 • 1 hour, 35 minutes, 34 seconds
Umbrella: Heart Failure, Panel 3, Acute Decompensated Heart Failure
Umbrella: HF, Acute Decompensated HF
9/16/2022 • 1 hour, 46 minutes, 48 seconds
Case Discussion 56 Answer
Case Discussion 56 Answer
9/10/2022 • 7 minutes, 13 seconds
ESC 2022 congress coverage: ALL-HEART trial
ESC 2022: ALL-HEART trial
9/2/2022 • 1 minute, 55 seconds
ESC 2022 congress coverage: INVICTUS trial
ESC 2022: INVICTUS trial
9/2/2022 • 5 minutes
ESC 2022 congress coverage: DANCAVAS trial
ESC 2022: DANCAVAS trial
9/2/2022 • 4 minutes, 29 seconds
ESC 2022 congress coverage: DELIVER trial
ESC 2022: DELIVER trial
9/2/2022 • 2 minutes, 26 seconds
ESC 2022 congress coverage: DANFLU-1 trial
ESC 2022: DANFLU-1 trial
9/2/2022 • 2 minutes, 44 seconds
ESC 2022 congress coverage: REVIVED trial
ESC 2022: REVIVED trial
9/2/2022 • 2 minutes, 25 seconds
ESC 2022 congress coverage: TIME trial
ESC 2022: TIME trial
8/27/2022 • 2 minutes, 9 seconds
ESC 2022 congress coverage: SECURE trial
ESC 2022: SECURE trial
8/27/2022 • 2 minutes, 3 seconds
Hypertension and Hyperlipidemia Academy No. 10 - Part 2
H&H Academy No. 10
8/27/2022 • 1 hour, 24 minutes, 5 seconds
ESC 2022 congress coverage: PERSPECTIVE trial
ESC 2022: PERSPECTIVE trial
8/27/2022 • 4 minutes, 43 seconds
A preview of ESC congress 2022
A preview of ESC congress 2022
8/27/2022 • 8 minutes, 59 seconds
ESC 2022 congress coverage: ADVOR trial
ESC 2022: ADVOR trial
8/27/2022 • 2 minutes, 13 seconds
Hypertension and Hyperlipidemia Academy No. 10 - Part 1
H&H Academy No. 10
8/27/2022 • 1 hour, 6 minutes, 22 seconds
Case Discussion 50 Answer
Case Discussion 50 Answer
8/20/2022 • 3 minutes, 44 seconds
CardioWatch, Season 2 Episode 4
CardioWatch S02E04
8/13/2022 • 11 minutes, 16 seconds
Case Discussion 47 Answer
Case Discussion 47 Answer
8/13/2022 • 11 minutes, 16 seconds
Antiplatelet Journal Scan
An Update on Antiplatelet Therapy
8/6/2022 • 22 minutes, 47 seconds
Instacath Conference 17
Instacath Conference 17
8/6/2022 • 10 minutes, 36 seconds
Hypertension and Hyperlipidemia Academy, 10: for non-physician healthcare profesionals - part 1
H&H Academy 10, for non-physician healthcare professionals
8/4/2022 • 1 hour, 12 minutes, 7 seconds
Case Discussion 51 Answer
Case Discussion 51 Answer
8/3/2022 • 10 minutes, 45 seconds
Case Discussion 49 Answer
Case Discussion 49 Answer
8/3/2022 • 5 minutes, 29 seconds
Case Discussion 48 Answer - Case Discussion 48 Answer
Case Discussion 48 Answer
8/3/2022 • 10 minutes, 51 seconds
Case Discussion 48 Answer - Case Discussion 48 Answer
Case Discussion 48 Answer
8/3/2022 • 10 minutes, 51 seconds
Vision: Vol. 2, Distal DVTs
The Second episode of Vision: distal DVTs
8/3/2022 • 10 minutes, 35 seconds
InstaCath Conference 15
Instacath Conference 15
8/3/2022 • 22 minutes, 16 seconds
Hypertension and Hyperlipidemia Academy, 10: for non-physician healthcare professionals - part 2
H&H Academy 10, for non-physician healthcare professionals
8/3/2022 • 52 minutes, 14 seconds
Case Discussion 46 Answer
Case Discussion 46 Answer
7/21/2022 • 12 minutes, 13 seconds
Familial hypercholesterolemia, a narrative review, part 3: management
FH 3: management
7/16/2022 • 19 minutes, 6 seconds
Vision: Vol. 1, What is Lp(a)?
The first episode of Vision: Lp(a)
7/16/2022 • 11 minutes, 54 seconds
Hypertension and Hyperlipidemia Academy, 9th session - Part 2
9th session of H&H Academy
7/15/2022 • 1 hour, 19 minutes, 35 seconds
DCS 1401, Mitral regurgitation
Daily Cardiology Symposium 1401: Valvular heart disease
7/13/2022 • 23 minutes, 19 seconds
Hypertension and Hyperlipidemia Academy, 9th session - Part 1
9th session of H&H Academy
7/13/2022 • 1 hour, 34 minutes, 4 seconds
InstaCath Conference 16
InstaCath Conference 16
7/13/2022 • 7 minutes, 15 seconds
DCS 1401, Aortic insufficiency
Daily Cardiology Symposium 1401: Valvular heart disease
7/12/2022 • 27 minutes, 50 seconds
DCS 1401, Prosthetic valve malfunction
Daily Cardiology Symposium 1401: Valvular heart disease
7/12/2022 • 38 minutes, 31 seconds
DCS 1401, Permanent pacemakers
Daily Cardiology Symposium 1401: Device therapy in cardiovascular diseases
7/12/2022 • 33 minutes, 42 seconds
DCS 1401, Heart Failure With Improved EF
Daily Cardiology Symposium 1401: Heart Failure
7/12/2022 • 23 minutes, 24 seconds
DCS 1401, Heart Failure with preserved EF
Daily Cardiology Symposium 1401: Heart Failure
7/12/2022 • 28 minutes, 8 seconds
DCS 1401, Acute Decompensated Heart Failure
Daily Cardiology Symposium 1401: Heart Failure
7/12/2022 • 40 minutes, 59 seconds
DCS 1401, Implantable cardioverter defibrillators
Daily Cardiology Symposium 1401: Device therapy in cardiovascular diseases
7/9/2022 • 29 minutes, 55 seconds
DCS 1401, Rhythm control strategies in AF
Daily Cardiology Symposium 1401: Arrhythmia
7/8/2022 • 31 minutes, 6 seconds
DCS 1401, Cardiac resynchronization therapy
Daily Cardiology Symposium 1401: Device therapy in cardiovascular diseases
7/8/2022 • 19 minutes, 15 seconds
DCS 1401, Atrioventricular nodal reentry tachycardia (AVNRT)
Daily Cardiology Symposium 1401: Arrhythmia
7/8/2022 • 25 minutes, 45 seconds
DCS 1401, Premature ventricular complexes
Daily Cardiology Symposium 1401: Arrhythmia
7/8/2022 • 36 minutes, 56 seconds
DCS 1401, Abdominal Aortic aneurysm
Daily Cardiology Symposium 1401: Peripheral vascular diseases
7/8/2022 • 24 minutes, 38 seconds
DCS 1401, Peripheral arterial disease
Daily Cardiology Symposium 1401: Peripheral vascular diseases
7/8/2022 • 33 minutes, 54 seconds
DCS 1401, Carotid Artery Stenosis
Daily Cardiology Symposium 1401: Peripheral vascular diseases
7/8/2022 • 29 minutes, 21 seconds
DCS 1401, VTE prophylaxis in COVID-19
Daily Cardiology Symposium 1401: Venous thromboembolism (VTE) prophylaxis
7/8/2022 • 27 minutes, 59 seconds
DCS 1401, VTE prophylaxis in surgical patients
Daily Cardiology Symposium 1401: Venous thromboembolism (VTE) prophylaxis
7/8/2022 • 23 minutes, 36 seconds
DCS 1401, Chronic Coronary Syndrome
Daily Cardiology Symposium 1401: Revascularization in CAD
7/8/2022 • 26 minutes, 18 seconds
DCS 1401, VTE prophylaxis in pregnancy
Daily Cardiology Symposium 1401: Venous thromboembolism (VTE) prophylaxis
7/8/2022 • 28 minutes, 15 seconds
DCS 1401, Non-ST-elevation acute coronary syndrome
Daily Cardiology Symposium 1401: Revascularization in CAD
7/8/2022 • 36 minutes, 30 seconds
DCS 1401, Dyslipidemia
Daily Cardiology Symposium 1401: Pharmacotherapy in CAD
7/7/2022 • 31 minutes, 33 seconds
DCS 1401, ST-elevation Myocardial Infarction
Daily Cardiology Symposium 1401: Revascularization in CAD
7/7/2022 • 30 minutes, 7 seconds
DCS 1401, Hypertension
Daily Cardiology Symposium 1401: Pharmacotherapy in CAD
7/6/2022 • 30 minutes, 1 second
DCS 1401, Diabetes mellitus
Daily Cardiology Symposium 1401: Pharmacotherapy in CAD
7/3/2022 • 31 minutes, 8 seconds
Daily Cardiology Symposium 1401, Day 2 Panel 4: Valvular heart disease
DCS 1401: Valvular heart disease
7/3/2022 • 1 hour, 39 minutes, 58 seconds
Daily Cardiology Symposium 1401, Day 1 Panel 3: Venous thromboembolism (VTE) prophylaxis
DCS 1401: Venous thromboembolism (VTE) prophylaxis
7/3/2022 • 1 hour, 30 minutes, 28 seconds
Daily Cardiology Symposium 1401, Day 2 Panel 3: Heart Failure
DCS 1401: Heart Failure
7/2/2022 • 1 hour, 43 minutes, 27 seconds
Daily Cardiology Symposium 1401, Day 2 Panel 2: Device therapy in cardiovascular diseases
DCS 1401: Device therapy in cardiovascular diseases
7/2/2022 • 1 hour, 35 minutes, 55 seconds
Daily Cardiology Symposium 1401, Day 1 Panel 4: Peripheral vascular diseases
DCS 1401: Peripheral vascular diseases
7/2/2022 • 1 hour, 39 minutes, 48 seconds
Daily Cardiology Symposium 1401, Day 2 Panel 1: Arrhythmia
DCS 1401: Arrhythmia
7/2/2022 • 1 hour, 43 minutes, 23 seconds
Daily Cardiology Symposium 1401, Day 1 Panel 2: Revascularization in CAD
DCS 1401: Revascularization in CAD
7/2/2022 • 1 hour, 43 minutes, 28 seconds
Daily Cardiology Symposium 1401, Day 1 Panel 1: Pharmacotherapy in CAD
DCS 1401: Pharmacotherapy in CAD
7/1/2022 • 1 hour, 46 minutes, 10 seconds
Case discussion No. 44
Case discussion No. 44
7/1/2022 • 9 minutes, 43 seconds
Daily Cardiology Symposium 1401, opening remarks
DCS 1401: opening remarks
7/1/2022 • 12 minutes, 54 seconds
Case discussion No. 45
Case discussion No. 45
6/17/2022 • 19 minutes, 18 seconds
InstaCath Conference 14
InstaCath Conference 14
6/10/2022 • 5 minutes, 59 seconds
CardioWatch, Season 2 Episode 3
CardioWatch S02E03
6/10/2022 • 11 minutes, 5 seconds
Case discussion No. 41
Case discussion No. 41
6/6/2022 • 6 minutes, 31 seconds
Hypertension and Hyperlipidemia Academy, 8th session
8th session of H&H Academy
6/6/2022 • 2 hours, 48 minutes, 17 seconds
Case discussion No. 42
Case discussion No. 42
6/6/2022 • 2 minutes, 17 seconds
CardioWatch, Season 2 Episode 2
CardioWatch S02E02
5/21/2022 • 11 minutes, 36 seconds
Case discussion No. 43
Case discussion No. 43
5/21/2022 • 3 minutes, 14 seconds
American College of Cardiology (ACC) congress 2022 landmark trials review
ACC 2022 congress coverage
5/6/2022 • 2 hours, 7 minutes, 9 seconds
TicaHub 2: Ticagrelor in clinical trials
TicaHub 2
5/6/2022 • 22 minutes, 29 seconds
At a glance: Ticagrelor and prevention of recurrent thrombotic events in CCS
Ticagrelor and secondary prevention in CCS
4/29/2022 • 14 minutes, 5 seconds
CardioWatch, Season 2 Episode 1
CardioWatch S02E01
4/8/2022 • 10 minutes, 26 seconds
Case discussion No. 40
Case discussion (40)
3/17/2022 • 12 minutes
Hypertension and Hyperlipidemia Academy, 7th session
7th session of H&H Academy
3/17/2022 • 1 hour, 58 minutes, 9 seconds
Familial hypercholesterolemia, a narrative review, part 2: diagnosis and screening
FH 1: diagnosis and screening
3/17/2022 • 17 minutes, 16 seconds
Cardiometabolic grand round: session 6
The 6th cardiometabolic grand round
3/17/2022 • 49 minutes, 20 seconds
Umbrella: Hypertension, secondary hypertension
Umbrella: HTN, secondary HTN
3/12/2022 • 1 hour, 30 minutes, 47 seconds
Umbrella: Hypertension, hypertension and pregnancy
Umbrella: HTN, HTN and pregnancy
3/12/2022 • 1 hour, 36 minutes, 36 seconds
Umbrella: Hypertension, Acute severe hypertension
Umbrella: HTN, acute severe HTN
3/12/2022 • 1 hour, 35 minutes, 59 seconds
Umbrella: Hypertension, Challenges in the diagnosis & management of HTN
Umbrella: HTN, diagnosis and management of HTN
3/12/2022 • 1 hour, 26 minutes, 29 seconds
HeartCast 5: practical approach to the treatment of HFrEF
The fifth HeartCast: HFrEF management
3/6/2022 • 7 minutes, 18 seconds
HeartCast 4: practical approach to the treatment of HFrEF
The fourth HeartCast: HFrEF management
2/11/2022 • 7 minutes, 26 seconds
which prophylaxis? for whom? VTE prophylaxis panel discussion
Case-based panel discussion on VTE prophylaxis
2/7/2022 • 1 hour, 48 minutes, 59 seconds
Hypertension and Hyperlipidemia Academy: for nurses and medical assistants
H&H Academy: nurses and assistants
2/7/2022 • 1 hour, 55 minutes, 56 seconds
DiaBeat: The Beating Heart of Diabetes (2nd session)
2nd Diabetes Masterclass for Cardiologists
1/29/2022 • 1 hour, 32 minutes, 11 seconds
Cardiometabolic Grand Round (1)
A brief talk on DM management in patients with CVD
1/28/2022 • 51 minutes, 15 seconds
Umbrella Heart and Stroke: session 3, Atrial fibrillation screening
Umbrella H&S: session 3, AF screening
1/28/2022 • 1 hour, 22 minutes, 13 seconds
Umbrella Heart and Stroke: session 2, carotid stenosis and stroke
Umbrella H&S: session 2, carotid stenosis
1/28/2022 • 1 hour, 18 minutes, 41 seconds
Umbrella Heart and Stroke: session 4, Antithrombotic therapy for the secondary prevention of stroke
Umbrella H&S: session 4, secondary prevention of stroke
1/28/2022 • 1 hour, 27 minutes, 58 seconds
DCS 1400: session 6, Arrhythmia
The sixth panel of DCS 1400: Arrhythmia
1/27/2022 • 1 hour, 39 minutes, 25 seconds
Umbrella, CCS 1
Proper use of non-invasive tests for the diagnosis of chronic coronary syndrome
1/27/2022 • 1 hour, 38 minutes, 24 seconds
Umbrella, CCS 2
Symptom relief and event prevention through optimal medical therapy in chronic coronary syndrome
1/27/2022 • 1 hour, 37 minutes, 45 seconds
Umbrella, CCS 3
How to sensibly choose the invasive strategies in chronic coronary syndrom
1/27/2022 • 1 hour, 40 minutes, 22 seconds
DCS 1400: session 8, Valvular Heart disease
The eighth panel of DCS 1400: Valvular Heart disease
1/27/2022 • 1 hour, 40 minutes, 1 second
DCS 1400: session 5, HF
The fifth panel of DCS 1400: Heart Failure
1/27/2022 • 1 hour, 42 minutes, 42 seconds
DCS 1400: session 3, CCS
The third panel of DCS 1400: Chronic coronary syndrome
1/27/2022 • 1 hour, 37 minutes, 46 seconds
DCS 1400: session 1, HTN and DLP
The first panel of DCS 1400: hypertension and dyslipidemia
1/27/2022 • 1 hour, 40 minutes, 19 seconds
DCS 1400: session 2, Diabetes for cardiologists
The second panel of DCS 1400: diabetes for cardiologists
1/27/2022 • 1 hour, 35 minutes, 21 seconds
DCS 1400: welcome remarks
The initial greetings of DCS 1400
1/27/2022 • 20 minutes, 25 seconds
17th ECG Workshop: Broad and Narrow
How to have a fool proof way to diagnose tachycardia?
1/27/2022 • 1 hour, 56 minutes, 56 seconds
ECG Challenge (4)
ECG Case Scenarios
1/27/2022 • 7 minutes, 55 seconds
Pharmacological approach to ACS management in patients on DOAC
Challenges on fibrinolytic therapy and primary PCI issues in admitted ACS patients on DOACs
1/27/2022 • 28 minutes, 22 seconds
Finding the optimal thromboprophylaxis regimen in patients with COVID-19
Preventing thromboembolic events in COVID-19
1/27/2022 • 1 hour, 4 minutes, 20 seconds
DCS 1400: session 7, VTE
The seventh panel of DCS 1400: Venous Thromboembolism
1/27/2022 • 1 hour, 31 minutes, 11 seconds
DCS 1400: session 4, ACS
The fourth panel of DCS 1400: Acute coronary syndrome
1/27/2022 • 1 hour, 39 minutes, 37 seconds
Update on IVC Filters
Satellite Presentation: Tehran Thrombosis Congress
1/27/2022 • 22 minutes, 20 seconds
Daily Cardiology Conversation
GI Protection in Patients on Antithrombotic Agents
1/27/2022 • 30 minutes, 26 seconds
Cardiology Close-Up (8)
Stroke Prevention in Atrial Fibrillation
1/27/2022 • 35 minutes, 22 seconds
Cardiology Close-Up (10)
Antithrombotic Therapy in Patients with Chronic Coronary Syndrome and in Sinus Rhythm
1/27/2022 • 36 minutes, 43 seconds
Cardiology Close-Up (3)
Statin Associated Muscle Adverse Events
1/27/2022 • 37 minutes, 39 seconds
Cardiology Close-Up (5)
Coronary Calcium Score and Cardiovascular Risk
1/27/2022 • 27 minutes, 34 seconds
Cardiology Close-Up (9)
Diagnosis and Treatment of Hypertension in Pregnancy
1/27/2022 • 48 minutes, 1 second
Cardiology Close-Up (2)
Antiplatelet therapy in patients undergoing CABG
1/27/2022 • 16 minutes, 54 seconds
Cardiology Close-Up (4)
Use of Beta Blockers in HF with reduced EF
1/27/2022 • 42 minutes, 17 seconds
Cardiology Close-Up (6)
Oral Anticoagulation in Venous Thromboembolism
1/27/2022 • 33 minutes, 28 seconds
Cardiology Close-Up (7)
Pharmacologic Therapy for LDL Cholesterol Treatment Goal and Pharmacologic Therapy for LDL Cholesterol
1/27/2022 • 36 minutes, 16 seconds
Cardiology Close-Up (1)
Management of Antithrombotic Therapy in AFib Patients Undergoing PCI
1/27/2022 • 22 minutes, 7 seconds
Case Discussion (3)
Evidenced based discussion on routine cases of cardiology in clinical practice - Diagnostic approach and treatment of ASD
1/26/2022 • 7 minutes, 42 seconds
Insta Cath Conference (9)
Expert discussion on complex and interesting angiograms
1/26/2022 • 1 minute, 36 seconds
Insta Cath Conference (8)
Expert discussion on complex and interesting angiograms
1/26/2022 • 2 minutes, 15 seconds
Insta Cath Conference (7)
Expert discussion on complex and interesting angiograms
1/26/2022 • 1 minute, 56 seconds
Case Discussion (4)
Evidenced based discussion on routine cases of cardiology in clinical practice - Approach to wall motion abnormality in Echocardiography
1/26/2022 • 2 minutes, 47 seconds
Case Discussion (5)
Evidenced based discussion on routine cases of cardiology in clinical practice - Antithrombotic Therapy in CCS
1/26/2022 • 5 minutes, 7 seconds
Case Discussion (29)
Pharmacotherapy approach to ACE/ARB induced AKI in HFrEF patients
1/26/2022 • 24 minutes, 26 seconds
Case Discussion (18)
Asymptomatic Pre-excitation
1/26/2022 • 4 minutes, 16 seconds
Case Discussion (17)
Duration and Dose of OAC in VTE and Cancer
1/26/2022 • 5 minutes, 54 seconds
Insta Cath Conference (11)
Expert discussion on complex and interesting angiograms
1/26/2022 • 1 minute, 36 seconds
Case Discussion (24)
Frequent VPB in a lady with HTN and mild LV systolic dysfunction
1/26/2022 • 13 minutes, 38 seconds
Insta Cath Conference (10) – Second Opinion
Expert discussion on complex and interesting angiograms
1/26/2022 • 35 seconds
Case Discussion (19)
Optimal DM Management
1/26/2022 • 8 minutes, 52 seconds
Case Discussion (23)
Anticoagulation Management in HCM Patient on Amiodarone
1/26/2022 • 2 minutes, 59 seconds
Case Discussion (20)
Anticoagulant Prophylaxis in Mild COVID-19 Infected Outpatients
1/26/2022 • 1 minute, 51 seconds
Case Discussion (16)
Antithrombotic Therapy in LV Smokey Pattern
1/26/2022 • 4 minutes, 14 seconds
Case Discussion (15)
How low is too low?
1/26/2022 • 4 minutes, 1 second
Case Discussion (28)
VTE Prophylaxis After HFS
1/26/2022 • 5 minutes, 15 seconds
Case Discussion (31)
Calcium channel blocker related edema
1/26/2022 • 5 minutes, 18 seconds
Case Discussion (37)
Drug-Drug Interactions with DOACs
1/26/2022 • 6 minutes, 8 seconds
Case Discussion (21)
Infective Endocarditis Prophylaxis
1/26/2022 • 11 minutes, 58 seconds
Case Discussion (27)
Vitamin D Supplementation in Patients with Severe CAD
1/26/2022 • 4 minutes, 48 seconds
Case Discussion (30)
Optimal Antithrombotic Regimen Early & Late After Discharge in Patients Presenting With STEMI
1/26/2022 • 27 minutes, 25 seconds
Insta Cath Conference (12)
Expert discussion on complex and interesting angiograms
1/26/2022 • 1 minute, 1 second
Insta Cath Conference (13)
Expert discussion on complex and interesting angiograms
1/26/2022 • 1 minute, 1 second
Insta Cath Conference (13)- Second Opinion
Expert discussion on complex and interesting angiograms
1/26/2022 • 2 minutes, 5 seconds
Insta Cath Conference (10)
Expert discussion on complex and interesting angiograms
1/26/2022 • 2 minutes, 38 seconds
Case Discussion (12)
AF and Complex Elderlies
1/26/2022 • 13 minutes, 53 seconds
Case Discussion (10)
Management of HyperTG
1/26/2022 • 9 minutes, 27 seconds
Case Discussion (13)
AF and GIB
1/26/2022 • 19 minutes, 58 seconds
Case Discussion (14)
AF and Advanced CKD
1/26/2022 • 15 minutes, 43 seconds
Case Discussion (9)
VTE prophylaxis in medically ill outpatients
1/26/2022 • 1 minute, 19 seconds
Case Discussion (11)
Antithrombotics in AF and Bioprosthetic Valve
1/26/2022 • 7 minutes, 54 seconds
Case Discussion (7)
Approach to chest pain in a patient with a history of CCS in the era of COVID-19 pandemic
1/26/2022 • 3 minutes, 29 seconds
Insta Cath Conference (3)
Expert discussion on complex and interesting angiograms
1/25/2022 • 2 minutes, 8 seconds
Case Discussion (22)
Duration of Anticoagulation for Non-surgical Provoked VTE
1/25/2022 • 10 minutes, 12 seconds
Insta Cath Conference (4)
The second case of Daily Cardiology Cath-Conference
1/25/2022 • 3 minutes, 12 seconds
Insta Cath Conference (2)
Expert discussion on complex and interesting angiograms
1/25/2022 • 1 minute, 40 seconds
Case Discussion (26)
The optimal duration of beta-blocker therapy after myocardial infarction
1/25/2022 • 15 minutes, 21 seconds
Insta Cath Conference (5)
Expert discussion on complex and interesting angiograms
1/25/2022 • 9 minutes, 22 seconds
Insta Cath Conference (3) – Second Opinion
Expert discussion on complex and interesting angiograms
1/25/2022 • 5 minutes, 36 seconds
Case Discussion (8)
An ignored challenge in HTN management: Non-dippers An evidence-based discussion
1/25/2022 • 17 minutes, 51 seconds
Familial hypercholesterolemia, a narrative review, part 1: definition and burden
FH 1: Definition and burden
1/25/2022 • 9 minutes, 17 seconds
Insta Cath Conference (6)
Expert discussion on complex and interesting angiograms
1/25/2022 • 3 minutes, 34 seconds
Insta Cath Conference (1)
Expert discussion on complex and interesting angiograms
1/25/2022 • 2 minutes, 9 seconds
Case Discussion (6)
Anticoagulation in AF & MR A Concise Case Based Discussion
1/25/2022 • 18 minutes, 6 seconds
HeartCast 2: practical approach to the treatment of HFrEF
The second HeartCast: HFrEF management
1/25/2022 • 8 minutes, 5 seconds
HeartCast 3: practical approach to the treatment of HFrEF
The third HeartCast: HFrEF management
1/25/2022 • 7 minutes, 13 seconds
At a Glance: Approach to Ticagrelor-induced Dyspnea
Managing dyspnea induced by Ticagrelor
1/25/2022 • 6 minutes, 12 seconds
At a glance: preventing cardiovascular thrombotic event after ACS
Ticagrelor in preventing post-ACS thrombotic events
1/25/2022 • 11 minutes, 36 seconds
Dual RAAS inhibition in the treatment of systolic heart failure; at a glance Part two: Eplerenone in the guidelines
Latest guideline recommendations on the use of RAAS inhibitors in heart failure patients
1/25/2022 • 9 minutes, 13 seconds
Cardiopoint (12): Two-Drug Combinations as First-Step Antihypertensive treatment
Initial administration of two-drug combinations in HTN
1/25/2022 • 19 minutes, 40 seconds
HeartCast 1: practical approach to the treatment of HFrEF
The first HeartCast: HFrEF management
1/25/2022 • 10 minutes, 6 seconds
Self-measured blood pressure monitoring at home
What to teach the patients about recording their blood pressure themselves
1/25/2022 • 15 minutes, 58 seconds
CardioPoint (10): The growing burden of cardiovascular diseases
Emphasizing the importance of CVD prevention and management
1/25/2022 • 12 minutes, 8 seconds
What is new in the 2020 ESC Guideline for the diagnosis and management of Atrial Fibrillation
Part Four: LSM, bleeding management, pregnancy, POAF, sex related differences
1/25/2022 • 13 minutes, 5 seconds
CardioPoint (11): Antithrombotic therapy in patients with AF treated with OAC undergoing PCI
Quick Review of ACC 2020 Expert Consensus Pathway of Antithrombotic Management
1/25/2022 • 11 minutes
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
Part Three: Cardioversion, rhythm control, catheter ablation Long term anti arrhythmic drugs
1/25/2022 • 22 minutes, 2 seconds
Cardiopoint (13): Management of stage 1 hypertension in adults with low cardiovascular risk
Stage 1 HTN in low risk patients
1/25/2022 • 9 minutes, 29 seconds
Dual RAAS inhibition in the treatment of systolic heart failure; at a glance Part one: Eplerenone in the pipeline
Latest pieces of evidence regarding the use of RAAS inhibitors in heart failure patients
1/25/2022 • 9 minutes, 22 seconds
Apixaban Hub (4)
NOAC Choice
1/25/2022 • 15 minutes, 18 seconds
CardioPoint (1): Statins-Who is eligible?-Which dose?
A Brief Description on Practical Points in Cardiometabolic Field
1/18/2022 • 4 minutes, 32 seconds
Guideline Made Easy (5)
Practical Guide for treatment of high blood cholesterol Part Two
1/18/2022 • 4 minutes, 31 seconds
CardioPoint (3): NOACs in Elderly
A Brief Description on Practical Points in Anticoagulation
1/18/2022 • 6 minutes, 35 seconds
CardioPoint (2): NOAC Monitoring, Do NOACs Need Monitoring?
A Brief Description on Practical Points in Anticoagulation
1/18/2022 • 4 minutes, 50 seconds
PCSK9 Inhibition from bench to bedside (4)
Part Four: The Lower, The Better
1/17/2022 • 12 minutes, 18 seconds
PCSK9 Inhibition from bench to bedside (1)
Part One: A success story
1/17/2022 • 10 minutes, 44 seconds
CardioPoint (6): Treatment Target & Goal for LDL-Cholesterol
A Brief Description on Practical Points in Cardiometabolic Field
1/17/2022 • 7 minutes, 42 seconds
Guideline Made Easy (1)
Practical Guide for Treatment of High Blood Pressure (Part One)
1/17/2022 • 9 minutes, 22 seconds
Apixaban Hub (1)
When to use, when not to use & which dose?
1/17/2022 • 17 minutes, 42 seconds
Guideline Made Easy (4)
Practical Guide for treatment of high blood cholesterol Part One
1/17/2022 • 5 minutes, 17 seconds
Apixaban Hub (2)
Apixaban in the pipeline: landmark clinical trials
1/17/2022 • 15 minutes, 34 seconds
At a glance: ACEI and ARB in COVID-19 Era
The challenge of to use or not to use ACEI/ARBs in patients with COVID-19
1/17/2022 • 8 minutes, 12 seconds
At a glance; How dual pathway found its way into ESC guidelines?
Rivaroxaban on board for CCS
1/17/2022 • 8 minutes, 26 seconds
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
Updated changes in AF ESC 2020 compared to previous Guidelines (Part one)
1/17/2022 • 15 minutes, 2 seconds
PCSK9 Inhibition from bench to bedside (2)
Part Two: Clinical Trials
1/17/2022 • 9 minutes, 28 seconds
CardioPoint (4): Fixed-Dose Combination Pills in the Management of Hypertension
A Brief Description on Practical Points in Cardiometabolic Field
1/17/2022 • 5 minutes, 55 seconds
Cardiac involvement in COVID-19 infection
Cardiovascular complications of COVID-19
1/17/2022 • 31 minutes, 31 seconds
CardioPoint (8): When to consider drug treatment in hypertension?
A Brief Description on Practical Points in Cardiometabolic Field
1/17/2022 • 8 minutes, 2 seconds
Guideline Made Easy (3)
Practical Guide for Treatment of High Blood Pressure (Part Three)
1/17/2022 • 8 minutes, 46 seconds
At a glance; FDC role in HTN Pharmacotherapy
Fixed dose combination therapy in HTN Treatment
1/17/2022 • 7 minutes, 54 seconds
Apixaban Hub (3)
Apixaban in Clinical Practice
1/17/2022 • 23 minutes, 50 seconds
PCSK9 Inhibition from bench to bedside (3)
Part Three: PCSK9 Inhibitor in my practice
1/17/2022 • 14 minutes, 58 seconds
CardioPoint (5): NOACs in CKD
A Brief Description on Practical Points in Anticoagulation
1/17/2022 • 6 minutes, 17 seconds
CardioPoint (7): Selecting appropriate NOAC
A Brief Description on Practical Points in Anticoagulation
1/17/2022 • 8 minutes, 33 seconds
CardioPoint (9): Once vs. twice-daily NOACs and adherence considerations
A Brief Description on Practical Points in Anticoagulation
1/17/2022 • 1 minute, 36 seconds
Guideline Made Easy (2)
Practical Guide for Treatment of High Blood Pressure (Part Two)
1/17/2022 • 9 minutes, 11 seconds
At a glance; Place of FDC in CV outcomes
Single-Pill Combination Therapy and CV Outcomes in HTN
1/17/2022 • 4 minutes, 55 seconds
Guideline Made Easy (6)
Practical Guide for treatment of high blood cholesterol Part Three
1/17/2022 • 7 minutes, 4 seconds
DiaBeat: The Beating Heart of Diabetes (4th session)
4th Diabetes Masterclass for Cardiologists
1/15/2022 • 1 hour, 37 minutes, 5 seconds
DiaBeat: The Beating Heart of Diabetes (3rd session)
3rd Diabetes Masterclass for Cardiologists
1/15/2022 • 1 hour, 32 minutes, 11 seconds
DiaBeat: The Beating Heart of Diabetes (5th session)
5th Diabetes Masterclass for Cardiologists
1/15/2022 • 1 hour, 33 minutes, 19 seconds
Rivaroxaban vs Apixaban in major ischemic or hemorrhagic events in AF
Rivaroxaban vs Apixaban in AF
1/15/2022 • 2 minutes, 55 seconds
Antiplatelet journal scan
A review on recent antiplatelet therapy trials
1/15/2022 • 11 minutes, 57 seconds
Aspirin vs Clopidogrel for chronic maintenance monotherapy after PCI
The comparison of Clopidogrel and Aspirin monotherapy after PCI (HOST-EXAM trial)
1/15/2022 • 2 minutes, 36 seconds
Landmark trials of ESC 2021 congress
2021 post-ESC headlines
1/15/2022 • 1 hour, 33 minutes, 40 seconds
Cardio-Watch Podcast: Episode 4, Dyslipidemia
The fourth episode of Cardio-Watch: Dyslipidemia
1/15/2022 • 9 minutes, 34 seconds
Cardio-Watch Podcast: Episode 7, ESC 2021 special
The seventh episode of Cardio-Watch: ESC 2021
1/15/2022 • 9 minutes, 21 seconds
Impact: Statin treatment and muscle symptoms
StatinWise Trial
1/15/2022 • 2 minutes, 33 seconds
Testing for Iron deficiency and use of Ferric Carboxymaltose in HF patients
Diagnosis and management of Iron deficiency in HF patients
1/15/2022 • 2 minutes, 40 seconds
Cardio-Watch podcast: Episode 2, Hypertension
The second episode of Cardio-Watch: Hypertension
1/15/2022 • 11 minutes, 14 seconds
Impact: DAPT vs. Aspirin in patients with stroke or TIA
A recent meta-analysis about antiplatelet therapy in stroke
1/15/2022 • 2 minutes, 18 seconds
Therapeutic anticoagulation with Heparin in critically and non-critically ill patients with COVID-19
The role of Heparin in the management of thrombosis in COVID-19
1/15/2022 • 3 minutes, 44 seconds
Cardio-Watch Podcast: Episode 6, Electrophysiology
The sixth episode of Cardio-Watch: Electrophysiology
1/15/2022 • 8 minutes, 24 seconds
Effect of Neprilysin Inhibition on LV Remodeling in Asymptomatic LV Systolic Dysfunction After MI
Neprilysin Inhibitors to prevent LV remodeling post MI
1/15/2022 • 3 minutes, 35 seconds
Cardio-Watch podcast: Episode 3, Atrial fibrillation and Flutter
The Third episode of Cardio-Watch: AF
1/15/2022 • 11 minutes, 41 seconds
A review on four landmark anti-platelet therapy trials
The latest updates on anti-platelet therapy from 4 important trials
1/15/2022 • 7 minutes, 52 seconds
Left Atrial Appendage Occlusion to prevent Stroke
Preventing Stroke by surgical LA Appendage Occlusion
1/15/2022 • 2 minutes, 50 seconds
Cardio-Watch Podcast: Episode 1, COVID-19 and the heart
The first episode of Cardio-Watch podcast
1/15/2022 • 11 minutes, 28 seconds
Cardio-Watch Podcast: Episode 5, cardiometabolic disorders
The fifth episode of Cardio-Watch: cardiometabolic disorders
1/15/2022 • 9 minutes, 24 seconds
Impact: the paradox of physical activity in cardiovascular disease
The contemporary Copenhagen general population study
1/15/2022 • 2 minutes, 35 seconds
Impact: No-LVT trial
Comparative study of oral anticoagulation in left ventricular thrombi
1/15/2022 • 2 minutes, 29 seconds
Midodrine for the prevention of vasovagal syndrome: a randomized clinical trial
Midodrine in vasovagal syndrome prevention
1/15/2022 • 1 minute, 57 seconds
Safety and Efficacy of different antithrombotic strategies after TAVI
Post-TAVI antithrombotic strategies
1/15/2022 • 2 minutes, 38 seconds
Long-term event-free and overall survival with Dapagliflozin in HFrEF patients
Impact of Dapagliflozin on the survival of HFrEF patients
1/15/2022 • 2 minutes, 26 seconds
Milrinone compared with Dobutamine in cardiogenic shock: DOREMI trial
Milrinone vs. Dobutamine: DOREMI trial
1/15/2022 • 1 minute, 39 seconds
Dapagliflozin in non-DM Patients with HF and Reduced EF
The findings of DAPA-HF trial in non-diabetics
1/15/2022 • 3 minutes, 54 seconds
Benefits of Targeting for a
The findings of TST study
1/15/2022 • 2 minutes, 30 seconds
Electrical versus pharmacological cardioversion for acute AF in emergency settings
The findings of RAFF2 trial
1/15/2022 • 2 minutes, 24 seconds
Daily Cardiology Journal Club: First Session – How to setup an effective Journal Club?
Monthly Case-Based Clinical Problem Solving
1/15/2022 • 45 minutes, 48 seconds
Dapagliflozin in concurrent Atrial Fibrillation and T2DM
Insights from DECLARE-TIMI 58 Trial
1/15/2022 • 1 minute, 38 seconds
Daily Cardiology Journal Club: First Session – How to setup an effective Journal Club?
Monthly Case-Based Clinical Problem Solving
1/15/2022 • 45 minutes, 48 seconds
Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
Monthly Case-Based Clinical Problem Solving
1/15/2022 • 59 minutes, 55 seconds
Predicting the Risk of Post-stroke Atrial Cardiopathy
An interim analysis from ACARDIA trial
1/15/2022 • 2 minutes, 4 seconds
Intensive LDL lowering beyond current recommendations for MACE prevention
A meta-analysis of RCTs
1/15/2022 • 2 minutes, 47 seconds
Daily Cardiology Journal Club: 4th Session – EAST-AFNET4 Trial
Monthly Case-Based Clinical Problem Solving
1/15/2022 • 59 minutes, 55 seconds
OACs vs. antiplatelet or placebo for stroke prevention in patients with HF and sinus rhythm
A meta-analysis of RCTs
1/15/2022 • 1 minute, 38 seconds
Association of Anticoagulation Therapy with the Risk of Fracture in AF Patients
The findings of a recent study
1/15/2022 • 1 minute, 48 seconds
Daily Cardiology Journal Club: Second Session – ISCHEMIA Trial
Monthly Case-Based Clinical Problem Solving
1/15/2022 • 1 hour, 18 minutes, 56 seconds
Intensive Blood Pressure lowering and the Concerns about Falling
The findings of SPRINT trial
1/15/2022 • 1 minute, 53 seconds
Complete vs. Culprit-only Revascularization in Patients with STEMI and Multi-Vessel Coronary Disease
A meta-analysis of RCTs
1/15/2022 • 2 minutes, 5 seconds
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in T2DM
The renal and cardiovascular protective effects of SGLT2 inhibitors
1/15/2022 • 2 minutes, 32 seconds
Timing of Staged Non-Culprit Artery PCI in STEMI
The findings of COMPLETE Trial about PCI timing
1/15/2022 • 2 minutes, 23 seconds
Inclisiran for patients with ASCVD and elevated LDL
The findings of ORION-10 trial in ASCVD patients
1/15/2022 • 3 minutes, 20 seconds
The Efficacy and Safety of Low-Dose Colchicine after MI
The findings of COLCOT trial about colchicine post-MI
1/15/2022 • 1 minute, 59 seconds
Optimal Medical Therapy vs. Revascularization in Chronic Coronary Syndrome
The findings of ISCHEMIA trial
1/15/2022 • 4 minutes, 42 seconds
Antithrombotic treatment after CABG
A recent meta-analysis on post-CABG Antithrombotic therapy
1/15/2022 • 2 minutes, 37 seconds
Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis
The findings of RECOVERY trial
1/15/2022 • 3 minutes, 38 seconds
AF after Non-Cardiac Surgery Increases the Risk of Stroke
A meta-analysis of post-operative AF studies
1/15/2022 • 2 minutes, 18 seconds
Triglyceride Lowering and Cardiovascular Risk Reduction
A Systematic Review and Meta-Analysis of RCTs on TG lowering drugs
1/15/2022 • 2 minutes, 49 seconds
Inclisiran in Heterozygous Familial Hypercholesterolemia (HeFH) and Elevated LDL
The findings of ORION-9 trial about Inclisiran in HeFH
1/15/2022 • 3 minutes, 16 seconds
Rivaroxaban vs. Vit K Antagonist in Antiphospholipid Syndrome
Rivaroxaban versus warfarin in APS
1/15/2022 • 2 minutes, 15 seconds
Ticagrelor with or without Aspirin in High-Risk patients after PCI
The findings of TWILIGHT Trial
1/15/2022 • 2 minutes, 55 seconds
Lisinopril vs Carvedilol for Trastuzumab Cardiotoxicity in Breast Cancer
Preventing the cardiotoxicity of Trastuzumab
1/15/2022 • 1 minute, 28 seconds
Acute vs Subacute Coronary Angiography in NSTEMI
The findings of NONSTEMI Trial
1/15/2022 • 2 minutes, 43 seconds
Peri-operative beta-blockers in non-cardiac surgery
The findings of Cochrane database systematic review
1/15/2022 • 3 minutes, 5 seconds
Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy
The findings of STICH trial
1/15/2022 • 59 seconds
OAC Monotherapy in Patients with Stable CAD and Non-valvular AF
OACs in Stable CAD and AF
1/15/2022 • 1 minute, 59 seconds
Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI
P2Y12 loading dose timing in PCI
1/15/2022 • 2 minutes, 16 seconds
Pantoprazole in Patients Receiving Rivaroxaban and/or Aspirin
The findings of COMPASS trial
1/15/2022 • 3 minutes, 13 seconds
Risk of Mortality Following Catheter Ablation of AF
Mortality risk after AF ablation
1/15/2022 • 59 seconds
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease
The findings of EXCEL Trial
1/15/2022 • 2 minutes, 46 seconds
Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half
The findings of REASTART Trial
1/15/2022 • 59 seconds
Ezetimibe for the prevention of heart disease and death
The role of Ezetimibe in reducing CVD adverse outcomes
1/15/2022 • 2 minutes, 40 seconds
Bedtime hypertension treatment improves cardiovascular risk reduction
The findings of Hygia Chronotherapy Trial
1/15/2022 • 2 minutes, 15 seconds
Anticoagulation in HF and sinus rhythm
OACs in HF and sinus rhythm
1/15/2022 • 1 minute, 37 seconds
TAVR vs SAVR: insights from ACC.19
The findings of PARTNER 3 and EVOLUT trials
1/15/2022 • 1 minute
Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or TIA
DAPT after ischemic stroke or TIA
1/15/2022 • 2 minutes, 30 seconds
Antithrombotic Therapy after ACS or PCI in AF
The findings of AUGUSTUS Trial
1/15/2022 • 3 minutes, 14 seconds
Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis
Stenting vs endarterectomy in symptomatic carotid stenosis
1/15/2022 • 59 seconds
Canagliflozin and Renal Outcomes in T2Dm and Nephropathy
The findings of CREDENCE Trial
1/15/2022 • 59 seconds
Hypertension and Hyperlipidemia Academy: 4th session
H&H Academy session 4
1/14/2022 • 1 hour, 52 minutes, 41 seconds
Ticagrelor Hub: when to use and which dose?
The dosage and indications of Ticagrelor
1/14/2022 • 16 minutes, 21 seconds
Management of dyslipidemia in diabetic patients
DLP and T2DM: approach and management
1/14/2022 • 23 minutes, 30 seconds
Umbrella Heart and Stroke: session 1, detecting & managing patients with PFO
Umbrella H&S: session1, PFO
1/14/2022 • 1 hour, 17 minutes, 45 seconds
Primary prevention in dyslipidemia as the only cardiovascular risk factor
Dyslipidemia in primary prevention of low-risk patients
1/14/2022 • 22 minutes, 54 seconds
Late-breaking Science in Cardiovascular disease prevention
ESC 2021 cardiovascular prevention guideline lectures and discussion
1/14/2022 • 3 hours, 21 minutes, 35 seconds
DiaBeat: The Beating Heart of Diabetes (8th session)
8th Diabetes Masterclass for Cardiologists
1/14/2022 • 1 hour, 41 minutes, 54 seconds
Cardiometabolic Grand Round (5)
The 5th session of Cardiometabolic grand round
1/14/2022 • 53 minutes, 26 seconds
An introduction to a new series; HeartCast
HeartCast introduction
1/14/2022 • 4 minutes, 3 seconds
The clinical landscape for Diabetes and Cardiovascular disease
T2DM and cardiovascular diseases: The clinical landscape
1/14/2022 • 26 minutes, 20 seconds
Hypertension and Hyperlipidemia Academy 5, a hybrid event
5th session of H&H Academy, online and onsite
1/14/2022 • 2 hours, 30 minutes, 37 seconds
DiaBeat: The Beating Heart of Diabetes (6th session)
6th Diabetes Masterclass for Cardiologists
1/14/2022 • 1 hour, 44 minutes, 23 seconds
Symptom matters: angina control in coronary artery disease
From surrogates to symptom control in CAD
1/14/2022 • 6 minutes, 7 seconds
Marking the antiplatelet therapy maze in ACS
How to prevent atherosclerotic cardiovascular events
1/14/2022 • 24 minutes, 55 seconds
DiaBeat: The Beating Heart of Diabetes (7th session), a scientific debate
7th Diabetes Masterclass for Cardiologists
1/14/2022 • 1 hour, 56 minutes, 44 seconds
Antithrombotic lighthouse, Cases and Faces: antithrombotic therapy in CAD
Antithrombotic regimens in CAD
1/14/2022 • 1 hour, 45 minutes, 57 seconds
From optimal medical therapy to revascularization in CCS
Choosing the best therapeutic strategy in CCS
1/14/2022 • 49 minutes, 1 second
Cardiovascular complications of T2DM: the preventive role of SGLT2Is
SGLT2Is and the prevention of cardiovascular complications in T2DM
1/14/2022 • 29 minutes, 16 seconds
Cardiometabolic Grand Round (4)
Guideline-directed cardiovascular evaluations before surgery
1/14/2022 • 54 minutes, 39 seconds
DCS 1400: session 8, Valvular Heart disease
The eighth panel of DCS 1400: Valvular Heart disease
1/14/2022 • 1 hour, 40 minutes, 1 second
Tailored Antithrombotic therapy for CCS patients
Best individual antithrombotic strategy in CCS
1/14/2022 • 25 minutes, 25 seconds
The evolution of antiplatelet therapy in CAD: a 45 year journey
A brief history of anti-platelet therapy in CAD
1/14/2022 • 15 minutes, 22 seconds
Dual antiplatelet therapy in2021: Current recommendations
The latest updates on DAPT
1/14/2022 • 1 hour, 33 minutes, 53 seconds
How to reduce the atherosclerotic cardiovascular risk
A case-based Review on HTN and DLP management
1/14/2022 • 1 hour, 30 minutes, 22 seconds
DiaBeat: The Beating Heart of Diabetes (1st session)
1st Diabetes Masterclass for Cardiologists
1/14/2022 • 2 hours, 1 minute, 2 seconds
PCSK9 inhibitors place in patients with cardiometabolic diseases
PCSK9 inhibitors from two perspectives of Endocrinologist & Cardiologist
1/14/2022 • 46 minutes, 51 seconds
Residents’ Island: Abidi CVD Prevention Academy
Multidisciplinary approach to CVD Prevention
1/14/2022 • 2 hours, 6 minutes, 19 seconds
Cardiometabolic Grand Round (3)
A brief talk on DM medication challenges in patients with CVD
1/13/2022 • 58 minutes, 29 seconds
7th Case: Thrombocytopenia
Any Concerns for OACs Use in Patients with Thrombocytopenia
1/13/2022 • 5 minutes, 52 seconds
5th Case: Stable ASCVD
Low dose Rivaroxaban in SIHD, COMPASS trial
1/13/2022 • 9 minutes
6th Case: Hepatic Impairment
OAC of choice in patients with hepatic impairment, any difference between DOACs?
1/13/2022 • 5 minutes, 38 seconds
8th Case: Intracranial Bleed
OAC Choice in High Thrombotic Risk Patients after ICH
1/13/2022 • 7 minutes, 39 seconds
10th Case: Drug Drug Interactions
DOACs important interactions in clinical practice
1/13/2022 • 6 minutes, 38 seconds
9th Case: Renal Insufficiency
OAC Management in Patients with CKD
1/13/2022 • 9 minutes, 21 seconds
4th Case: Extreme Body Weights
OAC choice in patients with obesity or low body weights, any role for DOACs?
1/13/2022 • 9 minutes, 33 seconds
3rd Case: AF & Artificial Heart Valves
OAC of choice in patients with artificial heart valves
1/13/2022 • 11 minutes, 30 seconds
2nd Case: Cancer associated VTE
Anticoagulation of choice in patients with cancer, the importance of DDI
1/13/2022 • 12 minutes, 58 seconds
1st Case: Elective PCI and AF
Antithrombotic regimen of choice in patients with AF undergoing elective PCI
1/13/2022 • 12 minutes, 57 seconds
SGLT2 inhibition: A snapshot into their evolution
Endocrinologist Perspective on SGLT2 inhibitors
1/13/2022 • 26 minutes, 51 seconds
SGLT2 inhibition: Making waves in the heart failure landscape
Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
1/12/2022 • 9 minutes, 36 seconds
Cardiometabolic Grand Round (2)
A brief talk on DM medication challenges in patients with CVD
1/12/2022 • 55 minutes, 23 seconds
Paradigm Shift in Treating Intermediate Risk Pulmonary Embolism
Concise Talk on Intermediate Risk Pulmonary Embolism, update by an expert in the field
1/11/2022 • 1 hour, 4 minutes, 25 seconds
How to Implement the Newest Diabetes Therapies in HF Treatment
New insight from EMPEROR Reduced Trial
1/11/2022 • 23 minutes, 3 seconds
What we learned from ESC Congress about HTN Management
A Brief Discussion on HTN Management Pearls of ESC 2020
1/11/2022 • 1 hour, 33 minutes, 34 seconds
VTE Prophylaxis in Patients with COVID-19
Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)
1/11/2022 • 45 minutes, 20 seconds
ESC 2020 Congress Coverage What is new on NSTE-ACS Guideline: a panel discussion
Brief Discussion on the New ESC Guideline on NSTE-ACS
1/11/2022 • 1 hour, 35 minutes, 35 seconds
Diabetes and Cardiovascular Diseases
On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
1/11/2022 • 9 minutes, 24 seconds
Smoking and the Heart the Struggle Continues
On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
1/11/2022 • 9 minutes, 37 seconds
Ground-breaking research from ESC Congress 2020 (23)
Part Twenty-three: Trial Review, ELDERCARE-AF
1/11/2022 • 5 minutes, 48 seconds
Ground-breaking research from ESC Congress 2020 (21)
Part Twenty-One: Trial Review, BPLTTC (CANCER)
1/11/2022 • 2 minutes, 29 seconds
Ground-breaking research from ESC Congress 2020 (22)
Part Twenty-Two: Trial Review, ATPCI
1/11/2022 • 3 minutes, 34 seconds
Ground-breaking research from ESC Congress 2020 (17)
Part Seventeen: Trial Review, REALITY
1/10/2022 • 4 minutes, 8 seconds
Ground-breaking research from ESC Congress 2020 (15)
Part Fifteen: Trial Review, PARALLAX
1/10/2022 • 3 minutes, 53 seconds
Ground-breaking research from ESC Congress 2020 (9)
Part Nine: Trial Review, RATE-AF
1/10/2022 • 6 minutes, 6 seconds
Ground-breaking research from ESC Congress 2020 (11)
Part Eleven: Trial Review, DAPA-CKD
1/10/2022 • 4 minutes, 40 seconds
Ground-breaking research from ESC Congress 2020 (20)
Part Twenty: Trial Review, POPULAR TAVI
1/10/2022 • 3 minutes, 20 seconds
Ground-breaking research from ESC Congress 2020 (14)
Part Fourteen: Trial Review, POPULAR CABG
1/10/2022 • 3 minutes, 27 seconds
Ground-breaking research from ESC Congress 2020 (19)
Part Nineteen: Trial Review, EXPLORER-HCM
1/10/2022 • 2 minutes, 31 seconds
Ground-breaking research from ESC Congress 2020 (18)
Part Eighteen: Trial Review, HOME-PE
1/10/2022 • 4 minutes, 38 seconds
Ground-breaking research from ESC Congress 2020 (4)
Part Four: Trial Review, BRACE-CORONA
1/10/2022 • 3 minutes, 20 seconds
Ground-breaking research from ESC Congress 2020 (12)
Part Twelve: Trial Review, EVAPORATE
1/10/2022 • 5 minutes, 16 seconds
Ground-breaking research from ESC Congress 2020 (16)
Part Sixteen: Trial Review, BPLTTC
1/10/2022 • 5 minutes, 2 seconds
Ground-breaking research from ESC Congress 2020 (3)
Part Three: Trial Review; THEMIS, PAD
1/10/2022 • 8 minutes, 51 seconds
Ground-breaking research from ESC Congress 2020 (1)
Congress Coverage: Introduction
1/10/2022 • 4 minutes, 38 seconds
Ground-breaking research from ESC Congress 2020 (10)
Part Ten: Trial Review, DECLARE-TIMI
1/10/2022 • 7 minutes, 16 seconds
Ground-breaking research from ESC Congress 2020
Brief Review of Main Trials Discussed in ESC Congress 2020
1/10/2022 • 1 hour, 56 minutes, 49 seconds
Ground-breaking research from ESC Congress 2020 (2)
Part Two: Trial Review, EMPEROR-REDUCED
1/10/2022 • 8 minutes, 18 seconds
Ground-breaking research from ESC Congress 2020 (5)
Part Five: Trial Review, EAST-AFNET4
1/10/2022 • 12 minutes, 55 seconds
Ground-breaking research from ESC Congress 2020 (13)
Part Thirteen: Trial Review, BAMI
1/10/2022 • 3 minutes, 6 seconds
Current Cardiology Practice of Antithrombotics in ASCVD: A Case Based Panel Discussion
Brief discussion on choice of antithrombotic agents in patients with chronic coronary syndrome and peripheral artery disease
1/10/2022 • 1 hour, 27 minutes, 15 seconds
Cardiometabolic Care Network
Interprofessional Collaboration Practice in Risk Management of ASCVD
1/10/2022 • 2 hours, 3 minutes, 28 seconds
Shielding the Brain From Stroke
A case based discussion on optimization of antithrombotic therapy in patients with ischemic stroke
1/10/2022 • 1 hour, 24 minutes, 38 seconds
Ground-breaking research from ESC Congress 2020 (7)
Part Seven: Trial Review, COLCOT
1/10/2022 • 4 minutes, 2 seconds
Ground-breaking research from ESC Congress 2020 (8)
Part Eight: Trial Review, COPS
1/10/2022 • 3 minutes, 15 seconds
Ground-breaking research from ESC Congress 2020 (6)
Part Six: Trial Review, LoDoCo2
1/10/2022 • 5 minutes, 55 seconds
Low-dose Rivaroxaban in Management of PAD Patients
Insights from COMPASS & VOYAGER Trials
1/10/2022 • 17 minutes, 56 seconds
Low-dose Rivaroxaban in Management of Post-Revascularized CAD Patients
Insights from COMPASS-PCI & COMPASS-CABG Trials
1/10/2022 • 21 minutes, 2 seconds
COVID-19 and thrombotic or thromboembolic disease: implication for prevention, antithrombotic therapy, and follow up
Antithrombotic challenge in patients with COVID-19; focus on JACC State of ART review
1/10/2022 • 1 hour, 27 minutes, 46 seconds
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19)Hydroxychloroquine: A magic bullet?
The role of medications in the pre and post prophylaxis against COVID-19
1/10/2022 • 1 hour
COVID and Cardiometabolic Challenges
Multidisciplinary approach to COVID-19 Cardiometabolic Complications
1/10/2022 • 1 hour, 58 minutes, 4 seconds
The evolving pandemic of COVID-19 and invasive cardiology consideration
Brief description of COVID-19 effect on approaching invasive strategies in patients with CVD
1/9/2022 • 1 hour, 21 minutes, 40 seconds
COVID-19 Cath Lab Implications
A frontline View from Italy
1/9/2022 • 1 hour, 11 minutes, 48 seconds
COVID-19 Sharing Facts, Not the Fear
Quick review on COVID-19 from an ID Perspective
1/9/2022 • 52 minutes, 32 seconds
Ischemic Cardiomyopathy to be Revascularized and How?
Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline
1/9/2022 • 19 minutes, 40 seconds
How to Select Appropriate Testing?
Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline
1/9/2022 • 29 minutes, 49 seconds
Anti-ischemic Medications
Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline
1/9/2022 • 27 minutes, 29 seconds